Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis

Published:2022 Issue: Volume: Page:527-567
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Aluko Atinuke,Ranganathan Prabha

Publisher

Springer US

Link

https://link.springer.com/content/pdf/10.1007/978-1-0716-2573-6_19

Reference162 articles.

1. Weinblatt ME, Coblyn JS, Fox DA et al (1985) Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312(13):818–822

2. Bathon JM, Martin RW, Fleischmann RM et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343(22):1586–1593

3. Bluett J, Sergeant JC, MacGregor AJ et al (2018) Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study. Arthritis Res Ther 20(1):50

4. Hooijberg JH, Broxterman HJ, Kool M et al (1999) Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res 59(11):2532–2535

5. Barredo JC, Synold TW, Laver J et al (1994) Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia. Blood 84(2):564–569

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between <i>COMMD1</i> gene polymorphism rs11125908 and rheumatoid arthritis in the Cuban population;Reumatismo;2024-06-24

2. IGF2BP3 regulates the expression of RRM2 and promotes the progression of rheumatoid arthritis via RRM2/Akt/MMP-9 pathway;PLOS ONE;2024-05-31

3. Association between the COMMD1 gene polymorphism rs11125908 and rheumatoid arthritis in the Cuban population;2023-08-29